1. Health
Send to a Friend via Email

Discuss in my forum

Carol Eustice

Otrexup Approved by FDA for Arthritis

By October 19, 2013

Follow me on:

On October 14, 2013, the U.S. Food and Drug Administration approved Otrexup (methotrexate). Certainly methotrexate is not a new drug, but Otrexup is a once-weekly, single dose, disposable auto-injector which has been designed for self-administration.

According to its maker Antares Pharma, Inc., Otrexup is indicated for adults with severe active rheumatoid arthritis, children with active polyarticular juvenile idiopathic arthritis, and severe psoriasis that is not responsive to other treatments. Methotrexate has long been available as oral tablets and in an injectable form which required patients to use a syringe and vial of methotrexate solution. With the easy-to-use auto-injector, Otrexup will provide another option for patients who prefer to self-inject methotrexate but may have been unable to do so because of hand arthritis, fear of needles, or lack of confidence. The availability of Otrexup is planned for early 2014.

Related Articles:

Stay Connected:

Facebook | Twitter | Google+ | Message Board | Newsletter

No comments yet. Leave a Comment
Leave a Comment

Line and paragraph breaks are automatic. Some HTML allowed: <a href="" title="">, <b>, <i>, <strike>

©2014 About.com. All rights reserved.

We comply with the HONcode standard
for trustworthy health
information: verify here.